Optio provides comprehensive commercial know-how, deep expertise, and integrated services with a global reach. Optio has delivered quality market research, new product planning (NPP)/strategic advisory services, competitive intelligence, and other customized commercial pharmaceutical services to US, European and Japanese healthcare companies since 2007. While Optio has worked in large prevalence disease markets, we have extensive experience in rare disease commercial strategy and services including orphan drug specialty pharmacy distribution. For more information please visit our website or contact us a 650 308 4999 or Admin@OptioLLC.com